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Understanding adherence 
to reactive treatment 
of asymptomatic malaria infections 
in The Gambia
Fatou Jaiteh1,2,3*, Joseph Okebe1,4, Yoriko Masunaga2,3, Umberto D’Alessandro1, 
Jane Achan1, Charlotte Gryseels2, Daniel de Vries3, Joan Muela Ribera5 & 
Koen Peeters Grietens2,5,6
The impact of different types of reactive case detection and/or treatment strategies for malaria 
elimination depends on high coverage and participants’ adherence. However, strategies to optimise 
adherence are limited, particularly for people with asymptomatic or no infections. As part of a 
cluster-randomized trial to evaluate the effect of reactive treatment in The Gambia, all residents 
in the compound of a diagnosed clinical malaria patient received dihydro-artemisinin–piperaquine 
(DP). Using a mixed method approach, we assessed which factors contribute to adherence among 
the contacts of malaria cases that showed no symptoms. Adherence was defined as the proportion of 
compound members that (1) returned all medicine bags empty and (2) self-reported (3-day) treatment 
completion. Among the 273 individuals from 14 compounds who received DP, 227 (83.1%) were 
available for and willing to participate in the survey; 85.3% (233/273) returned empty medicine bags 
and 91.6% (208/227) self-reported treatment completion. Although clinical malaria was not considered 
a major health problem, reported adherence was high. The drivers of adherence were the strong sense 
of responsibility towards protecting the individual, compound and the village. Adherence can be 
optimised through a transdisciplinary implementation research process of engaging communities to 
bridge the gap between research goals and social realities.
Malaria infected but asymptomatic carriers (i.e. apparently healthy individuals) can contribute to maintain 
malaria transmission when transmission intensity is  low1,2. Unlike clinical malaria cases who may actively seek 
treatment, apparently healthy individuals do not seek treatment for malaria and can carry malaria parasites for 
relatively long  periods3,4. These are targeted by several elimination strategies such as (1) mass drug administration 
(MDA), where treatment is provided to an entire population regardless of infection, and; (2) active case detec-
tion (ACD) where infections are detected actively by screening an entire population and then treating infected 
 individuals5. Reactive case detection (RACD), an important sub-type of ACD, treats individuals living around 
a confirmed clinical case with or without  screening5,6. The use of RACD is based on the clustering of malaria 
cases in space and time and the assumption that asymptomatic carriage is higher in the households of clinical 
malaria  cases6–8. These approaches, however, face several constraints such as unstandardised procedures for 
screening and/or treatment, limited sensitivity of standard diagnostic tests to detect low-density infections, high 
implementation costs, exclusion of at-risk groups such as pregnant women and infants < 6 months old, potential 
population exhaustion, acceptability and adherence challenges, treatment tolerability, risk of drug resistance, 
and little efforts to contextualise these  strategies5,6,9.
The success of these interventions depends heavily on treatment coverage (i.e. proportion of the target popu-
lation that received the treatment) and adherence (i.e. proportion of the target population actually taking the 
treatment). A successful MDA campaigns is usually conceptualised as achieving at least 80% coverage and 
adherence of the target  population10–12, which is often not reached. Moreover the barriers to treatment coverage 
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have received more attention than facilitators that determine adherence to treatment of apparently healthy 
 individuals13,14.
Integrating local, social contextual factors into the design of interventions, through community engagement 
and participation approaches, positively influences response to such  interventions9,11,15–20. These approaches 
include adapting messages about the intervention to community concerns on the impact of the disease, transmis-
sion dynamics, treatment tolerability, local patterns of mobility, involvement of the community in the design and 
implementation of key activities and, actively responding to raised concerns and  rumors11,13,16,17. These findings 
have been consistent in MDAs campaigns targeting neglected tropical diseases (NTDS)21,22. It is important to 
note that these observations were reported within the context of MDA with Directly Observed Treatment (DOT) 
performed by community volunteers, local health workers and/or external  organizations11,13,14,17,18,22. DOT, as a 
drug delivery strategy, is recommended by the World Health Organization (WHO)—where feasible—to ensure 
adherence to  treatment12. However, they are questions about the sustainability of this approach, its long-term 
feasibility, heavy burden placed on participants and ethical limitations. Studies on other infectious diseases 
have shown that adherence rates could be just as high when therapy is supervised by family members as when 
supervised by non-kin in a position of greater external  control23–25.
This mixed-methods study was conducted within but independent of a cluster-randomised trial (CRT) 
evaluating a RACD-type intervention, consisting of the systematic self-administered treatment of compound 
members of a passively detected clinical malaria case with a 3-day course of dihydroartemisinin-piperaquine 
(DP) (Clinical trials.gov, NCT02878200, 25/08/2016) in The Gambia. The adult patient or caregiver, in case of 
sick minors, was expected to provide treatment to his/her not-tested compound members with the assistance 
of the village health worker (VHW). The complexity and effectiveness of this “self-administered” DP treatment 
was assessed and addressed through a transdisciplinary process of concurrent designing and implementing 
of an active community participation  model26. This manuscript presents the factors contributing to treatment 
adherence of reactively identified at-risk compound members without symptoms.
Methods
Study site and population. The CRT and social science mixed-methods study were carried out in the 
North Bank Region of The Gambia. The main ethnic groups were Fula, Mandinka and Wolof, with the minor-
ity, belonging to the Bambara, Tilibonka and Turka. Mandinka and Fula are the main languages for commu-
nication and trade. The village structure comprises compounds defined by enclosed spaces containing one or 
several households belonging to the same extended patrilineal family. Gender ideology and roles situate men as 
household and compound heads. The compound head is often the oldest man in the family and his role includes 
overseeing family’s welfare, marriages, leading the agricultural productivity unit, household resource manage-
ment and making health-related decisions. A typical compound has rooms for adult men, for married women 
which they share with their children, and a ‘boys house’ for circumcised boys. Farming is the main activity, with 
peanut as the main cash crop; and, rice, maize, beans and vegetables as subsistence crops. Most family income is 
supplemented by remittances from relatives living either in urban areas at the coast or abroad.
Malaria transmission. Malaria transmission is seasonal, occurring mostly between August and December. The 
main malaria parasite species is Plasmodium falciparum27. Malaria transmission has declined substantially over 
the last 20 years, with a parasite prevalence at peak transmission estimated at 5%26. This decline has been attrib-
uted to a scale up of many interventions such as universal coverage of bed nets, indoor residual spraying and 
improved case  management28.
Access to medicine. Biomedical services consisted of a hospital in the main town and smaller health centers 
located along the main highway, providing basic care and health promotion. Road access is poor, and the com-
mon means of transport were horse- or donkey-drawn carts, walking and commercial vehicles. Villages with 
more than 400 residents have a VHW under the primary healthcare  scheme29. VHWs are selected by com-
munity leaders and trained by the government to provide basic health services such as health education and 
case management of uncomplicated malaria; diagnosis with a rapid diagnostic test (RDT); and treatment with 
artemether–lumefantrine (AL). Malaria treatment is provided free of charge and, where necessary, VHWs refer 
patients to the nearest primary health facility. VHWs are supervised by community health nurses (CHNs).
Familiarity with MDA. The study population have been exposed to several biomedical interventions which 
also includes trials on MDA for  malaria30,31. In 1999, MDA with artesuntate and pyrimethamine/suphadoxine 
(PSD) was carried out as part of a randomized double blinded study. Treatment was directly supervised by 
study nurses. Although the trial reported a coverage level of 85%, no overall benefit was observed. The study 
investigators indicated that perhaps a higher coverage was required for impact on malaria  transmission14,31. A 
follow up qualitative study reported barriers to uptake as related to the lack of adequate information given to the 
community members regarding the timing of the dosing, the possible side effects of the drugs, and the indefinite 
roles for the delivery and assessment of treatment. The investigation called for the need for continued sensitiza-
tion of community members to maintain and improve uptake of  MDA14. A second MDA carried out between 
June and August 2014 involved one round of directly observed treatment with DP administered by trial nurses 
and  fieldworkers30. A social science study ancillary to the trial reported that out of 3942 registered to participate, 
67.9% adhered to the three daily consecutive  doses13. The factors related to non-participation and adherence 
were long and short term mobility of the community members, perceived adverse drug reaction, rumours, logis-
tical concerns and perceived lack of  information13. Both studies highlight, the relevance of approaches which 
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contextualize the intervention to the social context to maximise its potential for participation and treatment 
 adherence13.
Implementing reactive treatment in the trial. Implementation of research process. A transdiscipli-
nary implementation research process identified social factors related to the effectiveness of the intervention 
and assessed solutions to potential problems identified by researchers, relevant community stakeholders, health 
service providers and policy makers. Potential changes and solutions were discussed in participatory workshops 
with community stakeholders, and implemented. The methodological approach, called the Community Lab of 
Ideas for Health (CLIH) consisted of (1) ethnography, (2) stakeholder analysis, (3) participatory workshops or 
‘Labs’ and (4) monitoring and evaluation. This process led to the design of a medicine distribution strategy and 
messages for community sensitisation based on local social structures and social  relations26.
Medicine distribution strategy. Once a clinical malaria case was diagnosed at a health facility by a study nurse, 
the adult patient or caregiver, in case of sick minors, received medicine bags with compound member’s name and 
dosing instructions to take home. The study nurse informed the VHW or village collaborator (VC)—a volunteer 
identified by the community in case of no resident VHW—of the event and compound where treatment has 
been sent. The VHW or VC then visited the compound the same day and distributed the medicines. When the 
clinical malaria case was diagnosed by the VHW, he visited the compound and distributed prepacked medicine 
to the compound members. VHW/VC distributed the medicines assisted by the compound/household head (or 
another family representative) with instructions on who should take the medicine, when and how. This included 
the specification that the 3-day course was to be taken once a day before breakfast for three consecutive days. 
Follow-up visits by the VHW/VC were scheduled for the day after treatment completion, at which time they 
checked whether the treatment had been taken, retrieved empty or unused medicine bags and inquired about 
any adverse events during the period. This information was relayed back to the study team, who recollected any 
unused pills and the medicine  bags26.
Study design. The study had a mixed-methods design, combining qualitative and quantitative research 
phases in all intervention villages (Fig. 1). The first phase of research (March and May 2016) involved gather-
ing ethnographic qualitative data for an in-depth understanding of contextual factors influencing adherence to 
treatment. In the second phase (September 2017–January 2018), both quantitative and qualitative data were col-
lected to assess adherence to treatment among those residing in the same compound with a diagnosed clinical 
malaria case. Quantitative data records of retrieved medicine bags and a self-reporting survey on adherence were 
complemented with qualitative semi-structured interviews to verify the findings from the prior quantitative and 
qualitative data.
Qualitative study. Data collection. Field work was a continuous process following an emergent theory 
design where initial qualitative findings guided subsequent structured data collection. Participant observation 
involved daily-life observations and reiterated informal conversations. Continuous conversations including in-
depth interviews with respondents helped in building confidence for discussions on treatment adherence.
Sampling. Purposive sampling was used throughout the study. The goal was to represent a variety of perspec-
tives on the topic under study. The perspectives chosen for relevance of the study on the topic of adherence 
were from (1) general community members and (2) compound members who received DP treatment. Based 
on the principle of gradual selection, respondents were theoretically selected (based on emerging results) and 
categorised in relation to relevant criteria (age, gender, ethnicity, social status, occupation, previous malaria 
experience, treated with DP, etc.). In addition, snowball sampling techniques was utilized whereby respondents 
identified other potential respondents.
Data analysis. All interviews were recorded and transcribed for analysis. Research notes were taken during 
and after the interview process whenever it was informal or inappropriate to record. Data analysis was a flexible 
and iterative process where emerging findings and hypothesis were continuously tested in the field until satura-
tion (i.e. no new findings emerging). The analytical induction process involved the iterative testing of theoreti-
cal ideas, which were used to refine and categorise themes grounded in the data whilst emerging themes were 
evaluated in dialogue with existing social science theory on adherence. This resulted in an adherence framework 
Exploratory qualitave 
phase 
Records of retrieved 
medicine bags 
N=273




Figure 1.  Flow chart of the study methodology and activities.
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that was systematically applied in subsequent data collection and analysis. All interviews were systematised and 
analysed with NVivo 11 Qualitative analysis software (QSR International Pty Ltd. Cardigan UK).
Quantitative study. Concept definition. For the quantitative study, “adherence” to DP was operational-
ised as the proportion of (1) compound members who returned complete medicine bags without pills and (2) 
compound members who self-reported to completing the 3-days treatment.
Data collection. Information on the medicine bags and pills was collected from the epidemiological records 
on all those who received the 3-day treatment. A structured, paper-based questionnaire survey evaluated the 
self-reported adherence of treated compound members. Questions assessed the use of DP, including the timing, 
frequency, dosage, observation and experienced adverse events. The forms were piloted before use to ensure 
clarity and to avoid translation errors in Fula, Mandinka and Wolof.
Sampling. All those who received the 3-day treatment were eligible for the survey. Children were represented 
by their designated caregivers. When targeted participants could not be reached, the reasons for non-participa-
tion were recorded in contact forms.
Data analysis. Completed questionnaires were double entered in Microsoft Access 15, verified and cleaned. 
Data was analysed using R (R version 3.3.0). Descriptive statistics were presented for the data and the association 
between related to adherence analysed using a regression model.
Ethical approval. The study was approved by the Gambia Government/MRC Joint Ethics committee (SCC 
1438v2, SCC 1484v2) and the Institutional Review Board of the Institute of Tropical Medicine, Antwerp, Bel-
gium (1046/15, 1144/16). All methods were performed in accordance with the relevant guidelines and regula-
tions. The interviewers followed the Code of Ethics of the American Anthropological Association (AAA)32. 
All interviewees were informed before the interview about the topic and types of questions and their right to 
decline participation, to interrupt or withdraw from the conversation. Informed consent was obtained from all 
participants and if participants are under 18, from a parent and/or legal guardian. Informed consent (oral) were 
preferred since the risk to the participant was minimal and the act of signing one’s name on a document could 
create mistrust since it is not customary practice within the local communities. Interviewees’ confidentiality was 
assured by assigning unique identifiers to the collected forms.
Results
Study participants. Qualitative study. A total of 108 in-depth interviews were carried out and 15 infor-
mal conversations were analysed across a range of respondents including village heads (Alkalos), index cases 
with clinical malaria and their caregivers, VHWs, compound and/or household heads and other community 
members (including those who received DP) (Table 1).
Quantitative study. 273 individuals were selected from the 14 compounds that received DP. 227 (83.1%) indi-
viduals were available and agreed to participate in the survey. The reasons for non-participation in the survey 
were moved away from the village (n = 21, 7.6%), travelling (n = 22, 8.0%), and inability to respond due to ill-
ness (n = 3, 1.0%). There were slightly more females (n = 120, 52.9%) than males (n = 104, 45.8%) and more than 
half of the individuals selected was single (n = 135, 59.4%). The biggest ethnic group was Fula (n = 150, 66.0%) 
(Table 2).
Quantifying treatment adherence to DP. Medicine bags and pill count. Treatment adherence to DP 
was estimated at 85.3% (233/273) when measured by the number of returned medicine bags and pills.
Table 1.  Overview of respondents for in-depth interviews and informal conversations.
Adult participants In-depth interviews and informal conversations




Index cases with clinical malaria (men and women) 5
Index case caregiver (women) 8
Compound members who received DP (men and women) 11
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Survey. 91.6% (208/227) of individuals reported to fully completing the treatment. Of those who participated, 
8 individuals (3.5%) admitted to not completing the treatment; this was justified by bitter taste, experienced 
chest pain after intake, forgetfulness, prior meal intake, vomiting after intake, travelling and work pressure. 
About half (52.4%, 119/227) of the respondents reported that their treatment was observed; mainly by caregiv-
ers. The difference between men and women was not statistically significant. (Table 3). We see a difference in 
treatment observation by caregivers in different age groups. The proportion observed by caregivers is 91.5% 
(43/47) for 0–5 years, 89.8% (44/49) for 6–12 years, 64.3% (27/42) for 13–18 years and 8% (7/87) for adults (p 
value < 0.001).
Table 2.  Socio-demographic characteristics of respondents in survey (N = 227).
Male (N = 104) Female (N = 120) NA
Marital status 17 (7.5%)
Single 75 (72.1%) 60 (50%)
Married 20 (19.2) 47 (39.2%)
Widowed/separated/divorced 0 (0%) 8 (6.7%)
Education level 11 (4.8%)
Primary 23 (23.1%) 14 (11.7%)
Secondary 8 (7.7%) 7 (5.8%)
Tertiary 1(1.0%) 0 (0%)
Arabic 23 (22.1%) 38 (31.7%)
Others 44 (42.3%) 58 (48.3%)
Ethnicity
Mandinka 0 (0%) 0 (0%)
Fula 68 (65.4%) 82 (68.3%)
Wolof 13 (12.5%) 10 (8.3%)
Bambara 6 (5.8%) 8 (6.7%)
Turka 2 (1.9%) 3 (2.5%)
Tilibonka 10 (9.6%) 14 (11.7%)
Table 3.  Self-reported adherence to DP treatment (N = 227).
Male (N = 104) Female (N = 120) NA p value
Medicine use 9 (4%) 0.33
Taken all pills 94 (90.4%) 114 (95.0%)
Have pills remaining 4 (3.8%) 3 (2.5%)
Pills received, not taken 1 (1.0) 0 (0%)
Pills not received 0 (0%) 0 (0%)
Time of day of taking pills 10 (4.4%) 0.12
Before breakfast 96 (92.3%) 117 (97.5%)
After breakfast 2 (1.9) 0 (0%)
Number of pills taken per day
Once 96 (92.3%) 117 (97.5%)
More than once 1 (1.0%) 0 (0%)
Number of days of taken pill 13 (5.7) 0.36
1 day 1 (1.0%) 2 (1.7%)
2 days 4 (3.8%) 1 (0.8%)
3 days 88 (84.6%) 111 (92.5%)
More than 3 days 2 (1.9%) 3 (2.5%)
Observation by 19 (8.4%) 0.01
Caregiver 63 (60.6%) 56 (46.7%)
Household head/compound head 1 (1%) 0 (0%)
Village health worker 0 (0%) 0 (0%)
MRCG nurse 0 (0%) 0 (0%)
Not observed 30 (28.8%) 56 (46.7%)
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Social drivers for adherence to DP. Social drivers for adherence to DP was researched using ethno-
graphic methods. We grouped results into two themes to demonstrate (1) how malaria risk perception and 
treatment of healthy individuals are conceptualised; and (2) how social influence and responsibility reinforced 
adherence.
Malaria risk perception. Perceptions on malaria transmission. Most people identified mosquitos to be 
the cause of malaria, during the rainy season. Increased malaria risk was associated with increased mosquito 
density related to presence of stagnant water (‘where the mosquitoes breed’) and ‘dirty areas’ with ‘lots of grass’ 
close to houses. Other perceived causes of malaria included ‘body heat transfer’ understood as the transmission 
of heat (and disease) through direct (e.g. sleeping together with a malaria case) or indirect (e.g. sleeping in the 
place where case was sleeping) contact, and eating from the ‘same bowl’, (as the disease could hide under the 
nails). These ideas shaped risk perceptions, which include staying close to an ill person and living too close to 
stagnant water. Furthermore, the idea that malaria could be hidden in the body without symptoms and remained 
transmissible was widely known and accepted. Indeed, most respondents reported that living in the same house-
hold/compound with a malaria case increased their personal risk of malaria infection. Most respondents per-
ceived that clinical malaria was less of a problem now than before. The perceived decline was attributed to regu-
lar cleaning of the environment, spraying of houses with insecticides and access to and use of bed nets provided 
by the government and the presence of the Medical Research Council, The Gambia (MRCG) in the study area.
Perceived impact of malaria. The impact of malaria was explicitly linked to the loss of agricultural productivity 
and the economy of the compound. In the words of a respondent ‘malaria does not only affect the ill person, 
because when one gets sick one cannot work, and this affects the entire compound’ (Adult man, farmer). The 
compound constituted not only a residential space but also the production unit; therefore, protecting an indi-
vidual from illness would avert its economic impact on the compound. An adult sick with malaria was consid-
ered to cost the compound about 3–5 working days and this had a significant impact on household economies 
(i.e. loss of 2–3 bags of harvest). In general, family members and friends often provided help for farming for free 
and out of solidarity. However, these gestures were limited during periods of heavy work pressure in the village. 
Few compounds with sufficient financial resources could offset some of this negative impact on productivity by 
securing a replacement worker during illness. The absence of key people on the farm could result in the loss of 
the crops due to the destruction by stray and wild animals.
Being sick could reduce my harvest. For example, when I start to dig the groundnuts and stop, the soil 
becomes dry so if I return back and start digging again all the groundnuts remain under the soil. This 
really affected my work which went backwards and is just yesterday that I was able to gather everything 
and bring it home (Adult man, farmer).
Conceptualisation of protection and prevention. Protecting oneself from acquiring illness or other mishaps was 
considered imperative. Commonly referred to as ‘fankanta’ (Mandinka), illness prevention is based on the idea 
that it is better to protect oneself before the illness (i.e. symptoms) comes out. Local self-protection practices 
ranged from wearing amulets or charms to prevent childhood illnesses, jinn (spirit) afflictions or ‘the evil eye’ 
during pregnancy. In this respect, informants considered the distribution of preventive medicine to the house-
holds to promote the health of its members as favourable. However, at the same time this conceptualisation had 
the potential to act as a barrier towards adherence to other malaria preventive measures. The study population 
had concerns on possible re-infection after treatment only if other infected members of their village remained 
untreated.
We believed that in taking the medicine we are protected from having malaria, but we also fear that if we 
live with the mosquitoes and they bite us we can still have malaria. Those compounds that don’t receive 
treatment are not protected. (Adult woman, farmer).
Informants explained that people who took the medicine were perceived as ‘protected’ from malaria for a period 
ranging from 6 months to 2 years, whilst those who did not were ‘not protected’.
Social influence and responsibility towards DP intake. Individuals with authority in health-related 
topics and those well-known and respected in the villages were particularly influential in reinforcing adherence 
to DP.
Compound head. The compound/household heads were the leader of the therapy management group (TMG) 
(i.e. individuals who took charge of therapy management with or on behalf of the ill person)33. Compound heads 
are considered exemplary role models and trusted to take decisions on medical treatment for ill compound 
members. The compound head’s tasks included arranging for transport and cash for accessing health facilities, 
and to organize substitute workers on the farm. Where the compound head was away, the role passed to a brother 
or the first wife. Compound members frequently mentioned that family members would easily accept to take 
the medicine if the compound head accepted the distribution of medication within the compound. Compound 
heads often felt it was their responsibility to encourage and remind family members of adherence to treatment. 
They would show this by taking DP themselves. Although respect for the compound head was considered as a 
motivating factor, most adult members stated that ultimately their decision to accept and adhere to the treat-
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ment was based more on their need to protect themselves from malaria, maintaining good health and remaining 
productive within their agricultural work unit.
Younger children were particularly seen as vulnerable to malaria so their mothers or other caregivers regarded 
it as their responsibility to personally observe medication intake. Older children or teenagers were regarded as 
more difficult to supervise for treatment. They were often away from the compound since they participated in 
agricultural work or herding which required them to leave the compounds early and return late in the evenings. 
Teenagers often mentioned that seeing their parents taking the medicine motivated them to take it as well.
VHWs. At the micro-political level of the village, the VHW’s influence over people’s decision to take the medi-
cation was regarded as important. Community members considered the VHWs as belonging to their commu-
nity and acting for the well-being of the residents. In addition, VHWs were seen as medicine providers due to 
their role in malaria case management, which was considered an important task. People’s trust in the VHW was 
reinforced when they felt better after the treatment he provided. The kinship relation of a compound with the 
VHW was considered an additional pressure for the compound to adhere to treatment. Some compound mem-
bers regarded not taking the medication as ‘negative behaviour’ since it could make them look ‘bad’ in the eyes 
of the VHWs and other community members in the village. Finally, community members, including VHWs, 
viewed the VHWs collaboration with the implementing institution (MRCG) as positive as this improved their 
social status.
MRCG . Most informants reported overall trust in the MRCG as the implementing institution. They frequently 
expressed confidence in the efficacy of the DP treatment provided by the MRCG. Trust was often related to 
previous positive experiences with projects implemented by the institution, which reportedly reduced suffering 
from malaria and the related economic losses. Despite the positive responses towards the treatment provided, 
they also expressed concerns on the temporary solution to health service delivery in their villages which often 
deteriorated at the end of such projects.
Discussion
With limited evidence-based approaches for optimising adherence to malaria elimination interventions, and the 
declining incidence in many pre-elimination settings, there is a growing need to understand drivers of treatment 
adherence in the apparently healthy individuals that may constitute the remaining parasite  reservoir34. Adher-
ence to DP was high when measured both by the number of returned medicine bags and pills (85.3%) as when 
self-reported (91.6%). Importantly, adherence was higher as comparison to a prior MDA trial implemented in 
the area with directly observed treatment (DOT)13. Within this study, adherence was reported as the propor-
tion of the study population who completed the three doses of DP (67.9%) when directly observed by a team of 
nurses and  fieldworkers13. This figure is far below the WHO minimum required adherence for successful MDA 
 campaigns11,12. The challenges mentioned for the study population, included MDA related inconveniences such 
as the long waiting times, burden of procedures, timing and  location13. Similar constraints were stated for another 
malaria MDA trial (which only reported coverage) implemented in the  area14. The WHO acknowledges situations 
where DOT is not feasible, nonetheless recommendations for alternative strategies largely neglect the available 
resources of the  family12. Our findings on the more complex reactive ‘’self-administered’’ treatment regime 
show that high treatment adherence can be achieved with the key involvement of family members or caregivers.
Treatment adherence was mainly reinforced by social factors. Despite the relatively low risk of transmission, 
motivation towards adherence was driven by a sense of responsibility to protect the individual, his/her family 
and the village, which was linked to the social structure and values of the community. Similar factors on treat-
ment adherence during MDA have been described in the  literature13,21. The perceived need of people adhering to 
preventive measures remained relevant as those living in the same compound with a malaria patient understood 
to be at risk due to both the presence of mosquitoes and an infected person. This in turn encouraged individual 
protection and responsibility towards preventing the impact of clinical malaria on the agricultural productivity 
of the  compound35,36.
For preventive interventions, including those aiming at elimination, where families or larger units may be 
targeted, the individual may not have the complete autonomy to participate and adhere to  treatment37,38. Often 
societal pressure against opting out is strong since the benefits of treatment can be perceived to go beyond the 
 individual38. This research shows that the sense of pressure within the compound to comply with treatment was 
related to the perceived risk of further transmission to other compound members. Although rarely acknowledged, 
this clear benefit for adherence presents the ethical dilemma of putting non-compliers at risk of discriminatory 
social action and  stigma38. Such adverse social impacts may result if interventions are implemented in ways 
which legitimize already held social prejudices against non-compliers39. This could manifest, for instance, if 
health messages relayed during community sensitization in elimination activities inadvertently label, those who 
do not adhere, as threats to its public health  benefits38,39. In promoting adherence, approaches should go beyond 
encouraging individual  responsibility16,40,41 and capitalize on shared  motivations9,42,43. Meaningful solutions could 
be reached through a participatory process of dialogue bridging the relevance of scientific intervention goals 
with the social realities of the affected communities.
In discussing avenues for facilitating adherence to treatment, the important role of trust in the MRCG, in 
the specific Gambian context, cannot be understated. In the study setting, the communities had a long political 
and engagement history with the implementing institution wherein trust in their role was mainly based on their 
reputation for providing good health care against the backdrop of a limited health  system44,45. VHWs who often 
collaborated with the MRCG in projects were considered as key stakeholders for further facilitating treatment 
acceptance and  adherence37,46. Nonetheless, community’s trust in the VHWs and their socio-political leverage was 
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fundamentally dependent on the VHWs perceived capacity to provide curative services for malaria. Community 
health providers may have insufficient status to motivate participation when their services are limited to health 
promotion rather than medicine  provision9,47. Exploring and advocating for sustainable solutions supporting 
VHWs in the broader health system and beyond trials remains  relevant48,49. While VHWs were perceived as key 
persons for biomedical health issues, the compound head was perceived as the gatekeeper of the compound. 
Involving compound heads in reinforcing adherence was crucial due to the local hierarchical structures and 
when linking adherence explicitly to the economic impact of the disease. Nevertheless, people often negotiate 
and have subtle ways of contesting authority, warranting the need for continuous dialogue to explore the sup-
plementary role of other influential compound members such as caregivers and other household  heads50 (Fig. 2).
Finally, high adherence to treatment was achieved within the context of a strategy of active community 
participation and collaboration between relevant community actors, health workers, researchers and trial 
 implementers26. The reactive medicine distribution system developed through the transdisciplinary and itera-
tive research process, shows that ethnographic methods can (1) provide contextualized relevant information; 
and (2) identify key community stakeholders (through stakeholder analysis) to facilitate discussions wherein 
researchers and community stakeholders negotiate the relevance of trial implementation. It further highlights the 
relevance of constant monitoring and evaluation of the implementation process to refine and improve developed 
strategies by utilising more of the community health resources.
Conclusion
The transdisciplinary research process of implementing reactive treatment addresses the call for strategies to 
facilitate adherence of apparently healthy individuals to malaria elimination interventions. The factors which 
reinforced adherence were socially related, mainly driven by a sense of responsibility towards protecting the 
individual, compound and the village. Meaningful dialogue towards community engagement can help bridge 
the gap between intervention goals and the social realities of the community.
Data availability
For the qualitative study, the datasets generated and/or analysed are not publicly available due to the fact that 
participants did not consent to have their full transcripts made publicly available. However, the NVivo database 
with excerpts of the transcripts relevant to the study is available from the corresponding author on reasonable 
request. For the quantitative study, the datasets used and/or analysed are available from the corresponding author 
on reasonable request.
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Figure 2.  A general adherence model depicting the factors related to enablers and obstacles.
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